Discoveries About Antibodies Provide Hope For Cancer Prevention

Dedication and perseverance are the tools used inconjugated, for cancer treatments.
the last thirty years to develop and approveA list of approved Mabs is available through the
antibodies for cancer prevention. MonoclonalACA's web site. In 2004 and in 2006, Bevacizumab, a
antibodies, or "Mabs", have been the result of medicalnaked antibody, was approved for treating certain
researchers' long and laborious hours behindtypes of breast cancers. In 2001 the FDA approved
microscopes, hoping to perfect the use of thesethe use of Alemuzumab, a naked antibody, which
cancer-fighting cells for doctors all over the world.acts as a form of leukemia prevention by attaching
What their discoveries have done for cancer patientsitself to both B and T cancer cells, causing the body's
is tremendous, especially since the number ofimmune system to attack and kill them. In 2000, the
individuals within the United States diagnosed withFDA approved the use of a conjugated antibody,
some form of cancer continue to rise each year. ByGemtuzumab ozogamicin, which is used in the
using Mabs, doctors and medical practitioners will havetreatment of chronic leukemia.
one more weapon to use against the silent, yetEach year cancer claims thousands of victims. Findings
deadly killer known as cancer.from the Pharmaceutical Research and Manufacturer
The American Cancer Society's (AMC) web siteof America show that more than 200,000 women will
explains that monoclonal antibodies were firstbe diagnosed with breast cancer, close to 150,000
developed in laboratories using mice with myelomamen and women will be diagnosed with colorectal
cells, which is a kind of bone marrow cancer, andcancer and over 30,000 men will die from prostate
mice that produced specific antibodies for those cells.cancer this year. Given these numbers, it is not hard
The combination of these two cells, called ato understand why the use and continual research of
hybridoma cell, forces a perpetual factory makingMabs is critical to our society.
antibodies. The antibodies end up being identicalThe recent approval of a vaccine used to protect
clones of the original hybridoma cell, which is whywomen from the Human Papilloma Virus, a known link
they are called monoclonal antibodies.to the development of cervical cancer, demonstrates
The problem scientists faced with this phenomenalthat research laboratories are on the brink of helping
finding was that human antibodies recognized thefind more antibodies for cancer prevention, providing
mouse-produced antibodies as foreign invaders andhope that the number of cancer patients will begin to
attacked them. With hard work and dedication,decline.
scientists are continuing to develop ways to integrateSuccess often outweighs the failures that scientists
human antibodies in lieu of mouse antibodies soand pharmaceutical researchers experience when
cancer patients will be able to use thetrying to successfully find treatments for cancer and
immunotherapy as a form of treatment.other deadly diseases. The triumphs experienced
Today there are two types of Mabs, naked andwithin the last several decades have come in the
conjugated. The difference between these two lies inform of antibodies for cancer prevention. The Mabs
the fact that naked antibodies lack radioactivethat have received approval by the FDA are now
materials attached to them. Conjugated antibodies,being used in the healing of cancer patients all over
on the other hand, are fused with a chemotherapythe world. As time goes by, these treatments will be
drug or other toxin used to fight off cancer cells. Infurther developed and perfected, helping lead the
recent years the Food and Drug Administration (FDA)way in cancer protection and treatment for
has approved several Mabs, both naked andgenerations to come.